EPGNF

Epigenomics Ag Berlin (QX) Stock Price

1.91
-0.61 (-24.21%)
1.91

Low
0.4259

52 Week Range

High
6.84

Best deals to access real time data!
Small Cap Basic
Monthly Subscription
for only
$33.03
Ultimate Trader (Monthly)
Monthly Subscription
for only
$80.29
DDE w/Realtime (Monthly)
Monthly Subscription
for only
$34.10
VAT not included
Company Name Stock Ticker Symbol Market Type
Epigenomics Ag Berlin (QX) EPGNF OTCMarkets Common Stock
  Price Change Change Percent Stock Price Last Traded
-0.61 -24.21% 1.91 16:09:57
Open Price Low Price High Price Close Price Prev Close
1.785 1.785 1.91 2.52
Bid Price Ask Price Spread News
1.72 2.04 0.32 - -
Trades Volume VWAP Dollar Volume Avg Volume 52 Week Range
2 1,094 $ 1.8894 $ 2,067 - 0.4259 - 6.84
Last Trade Time Type Quantity Stock Price Currency
15:16:20 914 $ 1.91 USD

Epigenomics Ag Berlin (QX) Financials

Market Cap Shares in Issue Float Revenue Profit/Loss EPS PE Ratio
$ 11.25M 5.89M - $ - $ - - -
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
- $ - 0.00% - -

more financials information »

Epigenomics Ag Berlin (QX) News

Loading Messages....

{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....


No posts yet, be the first! No {{symbol}} Message Board. Create One! See More Posts on {{symbol}} Message Board See More Message Board Posts

Historical EPGNF Price Data

Period Open High Low VWAP Avg. Daily Vol Change %
1 Week2.522.521.7852.521,250-0.61-24.21%
1 Month2.8153.081.7852.931,441-0.905-32.15%
3 Months3.123.26051.7852.923,241-1.21-38.78%
6 Months0.908856.840.42591.557,5181.00110.16%
1 Year1.21786.840.42592.0318,1860.692256.84%
3 Years4.356.840.42592.0014,757-2.44-56.09%
5 Years6.628.250.42592.4311,421-4.71-71.15%

Epigenomics Ag Berlin (QX) Description

Epigenomics is a molecular diagnostics company focused on blood-based detection of cancers using its proprietary DNA methylation biomarker technology. The company develops and commercializes diagnostic products across multiple cancer indications with high medical need. Epigenomics' lead product, Epi proColon, is a blood-based screening test for the detection of colorectal cancer. Epi proColon has received approval from the U.S. Food and Drug Administration (FDA) and is currently marketed in the United States, Europe, and China and selected other countries. Epi proLung, a test for lung cancer detection, and HCCBloodTest, a test for liver cancer, have received CE mark in Europe. For more information, visit www.epigenomics.com.


Your Recent History
USOTC
EPGNF
Epigenomic..
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.